 |
|
|
|
|
14 February 2012, Lysaker, Norway: Primary insider, CEO in Pronova BioPharmaASA, Morten Jurs, has bought 10 000 shares in the company today.
The shares were bought at an average share price of NOK 8.12 and are held by Jurs AS, which is owned 100 percent by Morten Jurs.
Total number of shares held by Mr Jurs after the purchase is 519 375 shares held by Jurs AS.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
HUG#1585335
|
|
|
|
|
| Copyright © Thomson Reuters 2012. All rights reserved. |
|
|
|
|
| European Press Release |
|
|
|
|
|
